Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology.
Cacciapaglia F, Spinelli FR, Erre GL, Gremese E, Manfredi A, Piga M, Sakellariou G, Viapiana O, Atzeni F, Bartoloni E. Cacciapaglia F, et al. Among authors: spinelli fr. Clin Exp Rheumatol. 2023 Sep;41(9):1784-1791. doi: 10.55563/clinexprheumatol/hyaki6. Epub 2023 Mar 2. Clin Exp Rheumatol. 2023. PMID: 36912349 Free article. Review.
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients.
Erre GL, Bartoloni E, Viapiana O, Gremese E, Atzeni F; “Cardiovascular, Obesity and Rheumatic Disease Study (CORDIS) Group” of the Italian Society of Rheumatology (SIR). Erre GL, et al. Eur J Intern Med. 2023 May;111:120-121. doi: 10.1016/j.ejim.2023.03.017. Epub 2023 Mar 21. Eur J Intern Med. 2023. PMID: 36948976 No abstract available.
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort.
Atzeni F, Cacciapaglia F, Galloways J, Manfredi A, Sakellariou G, Norton S, Gremese E, Spinelli FR, Viapiana O, Piga M, Erre GL, Bartoloni Bocci E. Atzeni F, et al. Among authors: spinelli fr. Autoimmun Rev. 2024 Feb;23(2):103478. doi: 10.1016/j.autrev.2023.103478. Epub 2023 Nov 11. Autoimmun Rev. 2024. PMID: 37956778
Editorial: JAK inhibition in autoimmune and inflammatory diseases.
Telliez JB, Gadina M, Ghoreschi K, Silvennoinen O, Spinelli FR. Telliez JB, et al. Among authors: spinelli fr. Front Immunol. 2022 Dec 28;13:1120281. doi: 10.3389/fimmu.2022.1120281. eCollection 2022. Front Immunol. 2022. PMID: 36643918 Free PMC article. No abstract available.
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
Caminati M, De Corso E, Ottaviano G, Pipolo C, Schiappoli M, Seccia V, Spinelli FR, Savarino EV, Gisondi P, Senna G. Caminati M, et al. Among authors: spinelli fr. Curr Allergy Asthma Rep. 2024 Jan;24(1):11-23. doi: 10.1007/s11882-023-01118-6. Epub 2023 Dec 12. Curr Allergy Asthma Rep. 2024. PMID: 38085499 Free PMC article. Review.
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D. Picchianti-Diamanti A, et al. Among authors: spinelli fr. Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684. Vaccines (Basel). 2023. PMID: 38006015 Free PMC article.
189 results